Why Biogen Inc. (BIIB) is stock facing headwinds despite recent FDA approval?
Biogen Inc. (BIIB) shares lost 0.01% in after-hours on Thursday, June 24, 2021, and closed the day at $349.13 per share. Earlier in the morning session, BIIB’s stock lost 6.11% to close Thursday’s session at $349.16. BIIB shares have risen 30.19% over the last 12 months, and they have moved down by 8.96% in the […]
Two of the Best Pharmaceutical Stocks to Watch for in 2021
Pharmaceutical stocks must be in investors’ heads due to their increased significance in the global pandemic. Let’s find out the pharma stocks that hold the most upside potential. The pharmaceutical industry makes an annual sale of over $1.2 trillion. The industry is already stable and has a huge market base. The COVID-19 pandemic has given […]
